Clinical Trial Update: Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability, PK, PD, and Comparative Bioavailability of THRV-1268 in Obese Adult Participants [Phase 1]

View source ↗

Summary

A Phase 1 single ascending dose study evaluating the safety, tolerability, PK/PD, and comparative bioavailability of THRV-1268 in obese adults with heart failur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Thrv-1268

Snippet

Sponsor: Thryv Therapeutics, Inc. | Conditions: Heart Failure | Phase 1 | Status: COMPLETED